By Kelly Cloonan

Lensar and Alcon agreed to terminate their merger agreement, citing expectations for pushback from the Federal Trade Commission.

Lensar, a medical technology company, said Monday the companies ended their agreement because they didn't expect to receive the necessary U.S. regulatory approvals in time to close the deal. The merger agreement had an outside date of April 23 and would have had a potential extended outside date of July 23.

Lensar Chief Executive Nick Curtis said the company is disappointed with the outcome and the FTC's intention to challenge the deal.

Lensar said it will retain the $10 million deposit contemplated by the merger agreement.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

March 16, 2026 17:22 ET (21:22 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.